Are you utilizing tokenization to gain wider insights about your clinical trial population outside of the confines of the trial? Learn more about recent changes and use cases for RWD enrichment studies at https://hubs.li/Q02C-DTL0 #PatientsFirst #RWD #RWE #ClinicalTrials
UBC
Pharmaceutical Manufacturing
Blue Bell, PA 28,562 followers
Patients First. Powered by Evidence.
About us
United BioSource LLC (UBC) is the leading provider of evidence development solutions with expertise in uniting evidence and access. UBC helps biopharma mitigate risk, address product hurdles, and demonstrate safety, efficacy, and value under real-world conditions. Underpinned by our scientific expertise, data and analytics, and innovative technologies, we offer our customers flexible solutions generating the relevant real-world data necessary to make more informed decisions earlier, meet stakeholder requirements, and ultimately, drive better patient outcomes.
- Website
-
http://www.ubc.com
External link for UBC
- Industry
- Pharmaceutical Manufacturing
- Company size
- 1,001-5,000 employees
- Headquarters
- Blue Bell, PA
- Type
- Privately Held
- Founded
- 2003
- Specialties
- Evidence Development, Modernized Study Design & Execution, Late-Stage Research, Risk Evaluation & Mitigation Strategies, Pharmacovigilance, Patient Access & Hub Services, Reimbursement & Patient Assistant Programs, and Nursing & Adherence
Locations
Employees at UBC
-
Radhika Rao
Senior Project Manager & Service Delivery Expert | Champion in Vendor Performance Oversight | IT Transformation Specialist | Strategic Leader
-
Rebecca Richardson
GQC CAPA administrator at UBC
-
Troy Mann
Manager - Program Management at UBC
-
Richard LeBoon PhD PCC
Executive Search Leader Connecting Executive Talent with New Career Opportunities and an Executive Performance Coach Helping Business Leaders Thrive…
Updates
-
Meet Myrto Ioannidi, MSc. Mrs. Ioannidi has over 10 years PV experience at UBC and currently leads a global team responsible for case processing, expedited reporting, literature review, safety database configuration and aggregate data outputs. As Director of Global Case Processing, Mrs. Ioannidi also acts as PV process lead for global and local literature and case automation. Read her full bio here. https://hubs.li/Q02Dc32x0 #PatientsFirst #Pharmacovigilance #SafetyandRiskManagement #PatientSafety
UBC Expert Spotlight: Myrto Ioannidi
pages.ubc.com
-
Don’t wait until increasing pharmacovigilance (PV) case volume overwhelms your resources. Implement UBC’s PV Case Automation Platform to easily control high-volume case processing with the automation of mailbox management, case intake, translation management, work assignment and more. Download our case study for insight into this real-time, scalable case automation solution to streamline your PV operations and cut costs. https://hubs.li/Q02DcxHt0 #PatientsFirst #Pharmacovigilance #SafetyandRiskManagement #PatientSafety #PVAutomation
Pharmacovigilance Case Automation Platform Case Study
https://ubc.com
-
We are excited to announce the expansion of our joint SitePlus offering in collaboration with THREAD. The expanded solution has been purposefully assembled to bring hybrid designs to life in the Phase II/III interventional clinical trial setting. SitePlus combines a nationwide investigator network, full-service study coordinator capabilities, and robust clinical trial home nursing reach, all connected and operating on a centralized technology platform. Click here to learn more https://hubs.li/Q02D9Pw70 #PatientsFirst #SitePlus #Pharma #ClinicalTrials #RWE
-
-
If you missed UBC's Innovation Theater at DIA 2024 last week you can catch up on our presentation topic. Read about RWD enrichment studies from UBC's Jeff Lowry and Irene Cosmatos at https://hubs.li/Q02C-DTJ0 #PatientsFirst #DIA2024 #RWD #RWE
RWD Enrichment Studies: Linking Pre- and Post-Trial Data Utilizing Tokenization
https://ubc.com
-
Patient access programs thrive when they are supported by actionable data and the right technology. Learn how UBC’s success for rare disease patients is evolving and impacting patients: https://hubs.li/Q02zmC5z0 #PatientsFirst #PatientAccess #PatientSupport #RareDisease
First-in-Class Therapy Succeeds with Personalized Patient Services
-
Meet Myrto Ioannidi, MSc. Mrs. Ioannidi has over 10 years PV experience at UBC and currently leads a global team responsible for case processing, expedited reporting, literature review, safety database configuration and aggregate data outputs. As Director of Global Case Processing, Mrs. Ioannidi also acts as PV process lead for global and local literature and case automation. Read her full bio here. https://hubs.li/Q02CrGBn0 #PatientsFirst #Pharmacovigilance #SafetyandRiskManagement #PatientSafety
UBC Expert Spotlight: Myrto Ioannidi
pages.ubc.com
-
Managing pharmacovigilance (PV) data optimization and adhering to evolving regulatory requirements doesn’t have to be a challenge. Experience seamless, real-time data visualization and compliance management with UBC’s PV Tableau Data Analytics Platform. Our solution is customized to your needs with an intuitive, dynamic data dashboard system and easy on-demand accessibility to generate powerful insights. Get the details: https://hubs.li/Q02CvbQP0 #PatientsFirst #Pharmacovigilance #SafetyandRiskManagement #PatientSafety #PVAnalytics
Pharmacovigilance Tableau Data Analytics Platform: All-in-One Dashboard System for PV Metrics and KPIs
https://ubc.com
-
It's the final day of DIA's Global Annual Meeting! Meet UBC at booth 2201 to get a live demo of our pharmacovigilance analytics platform or discuss our approach to modernized study designs. Learn more or contact our team directly at https://hubs.li/Q02Cm0Lh0 #PatientsFirst #DIA2024 #Pharma #PatientSafety
-
-
Meet Poonam Pathak. Mrs. Pathak has over 10 years of pharmacovigilance (PV) experience, with expertise in clinical trial and post-marketing for pharmaceutical products, leading case processing activities, literature review, data migration and aggregate reporting. As Team Manager, Global Case Processing, Mrs. Pathak oversees development of PV safety reporting and risk management plans. Read full bio here. https://hubs.li/Q02C1P4r0 #PatientsFirst #Pharmacovigilance #SafetyandRiskManagement #PatientSafety
-